QW Research
MarketsScreenerInstitutionsInsidersStatusInsightsAPIAboutFAQ
HomeAboutFAQ
Request data / API access →

Data from SEC EDGAR filings: company financials and 13F holdings.

Disclaimer: QW Research is provided for informational and educational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data is derived from public SEC 13F filings and may be incomplete, delayed, or inaccurate. Do not make investment decisions based on this content. QW Research does not share in any profits and accepts no liability for any losses or decisions made using this information. Past performance does not predict future results.

QW Research © 2026

Back to Insiders

Insider trades · 2026-09-06

53 transactions across 14 companies. 0 were decisions — 0 buys ($0) and 0 sales ($0), by 0 and 0 holders. The other 53 are grants, tax withholding, plan sales and option exercises.

Compensation mechanicsGrants, tax withholding, option exercises and pre-arranged plan trades. Shown because they are what most Form 4 volume is, and because they are reported elsewhere as ordinary buying and selling.

BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
Chairman & CEO
Tax withholding1,854$386.11$716k
INVX
Innovex International, Inc.
Anderson Adam
Chief Executive Officer
Tax withholding13,463$30.07$405k
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, Chief Financial Officer
Tax withholding782$386.11$302k
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, President, CDG
Tax withholding485$386.11$187k
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, President, LSG
Tax withholding470$386.11$181k
INVX
Innovex International, Inc.
Reed Kendal
Chief Financial Officer
Tax withholding5,049$30.07$152k
INVX
Innovex International, Inc.
Reddout Mark
President of North America
Tax withholding5,049$30.07$152k
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, General Counsel & Sec
Tax withholding305$386.11$118k
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, Global Supply Chain
Tax withholding277$386.11$107k
ACIW
ACI WORLDWIDE, INC.
Leibrock Robert William
Chief Financial Officer
Other1,905$52.95$101k
ALL
ALLSTATE CORP
2 co-filers
Group filing
Tax withholding213$259.57$55k
ACIW
ACI WORLDWIDE, INC.
Litch Erich J
GM, Payment Software
Other963$52.95$51k
EGHT
8X8 INC /DE/
Wilson Samuel C.
Chief Executive Officer
Tax withholding26,055$1.89$49k
FIVE
FIVE BELOW, INC
Gellerman Maureen Marie
CHRO
Tax withholding167$252.20$42k
ACIW
ACI WORLDWIDE, INC.
Shultz Ronald Craig
GM, ACI Speedpay
Other724$52.95$38k
EGHT
8X8 INC /DE/
Kraus Kevin
Chief Financial Officer
Tax withholding10,652$1.89$20k
EGHT
8X8 INC /DE/
Middleton Hunter
Chief Product Officer
Tax withholding10,226$1.89$19k
OSUR
ORASURE TECHNOLOGIES INC
Kenny John P.
Director
Tax withholding5,116$3.43$18k
OSPN
OneSpan Inc.
3 co-filers
Chief Financial Officer
Tax withholding897$16.70$15k
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
Group filing
Tax withholding34$386.11$13k
EGHT
8X8 INC /DE/
Denny Laurence
Chief Legal Officer
Tax withholding6,350$1.89$12k
KYNB
KYNTRA BIO, INC.
Wettig Thane
CEO
Tax withholding209$8.55$2k
BTGO
BITGO HOLDINGS, INC.
Fang Chen
Chief Revenue Officer
Tax withholding220$7.30$2k
BTGO
BITGO HOLDINGS, INC.
Reginelli Edward
Chief Financial Officer
Tax withholding88$7.30$642
BTGO
BITGO HOLDINGS, INC.
Mettler Jody
Chief Operating Officer
Tax withholding72$7.30$526
KYNB
KYNTRA BIO, INC.
Delucia David
Chief Financial Officer
Tax withholding22$8.55$188
ETOR
eToro Group Ltd.
2 co-filers
Group filing
Other33,848
holds 62,550 after
$0.00$0
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
Chairman & CEO
Option exercise3,455
holds 450,873 after
$0.00$0
OSPN
OneSpan Inc.
3 co-filers
Chief Financial Officer
Option exercise3,055
holds 95,318 after
$0.00$0
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, Chief Financial Officer
Option exercise1,536
holds 4,933 after
$0.00$0
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, President, CDG
Option exercise1,152
holds 2,313 after
$0.00$0
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, President, LSG
Option exercise1,056
holds 2,495 after
$0.00$0
DMC
DEL MONTE CORP
4 co-filers
SVP, NA Sales, Mkt & Prd Mgmt
Option exercise884
holds 3,444 after
$0.00$0
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, Global Supply Chain
Option exercise864
holds 3,880 after
$0.00$0
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, General Counsel & Sec
Option exercise768
holds 1,957 after
$0.00$0
ALL
ALLSTATE CORP
2 co-filers
Group filing
Grant483$0.00$0
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
Group filing
Option exercise92
holds 1,768 after
$0.00$0
DMC
DEL MONTE CORP
4 co-filers
SVP, NA Sales, Mkt & Prd Mgmt
Option exercise63$0.00$0
DXLG
DESTINATION XL GROUP, INC.
3 co-filers
EVP, Chief Growth Officer
Grant375,375$0.00—
DXLG
DESTINATION XL GROUP, INC.
3 co-filers
EVP, Chief Growth Officer
Grant74,936$0.00—
ETOR
eToro Group Ltd.
2 co-filers
Group filing
Other33,848
holds 0 after
$0.00—
DXLG
DESTINATION XL GROUP, INC.
3 co-filers
EVP, Chief Growth Officer
Grant21,474$0.00—
WYY
WIDEPOINT CORP
Sparling Ian
CEO, Soft-Ex
Option exercise10d late9,714$0.00—
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
Chairman & CEO
Option exercise3,455
holds 6,912 after
$0.00—
OSPN
OneSpan Inc.
3 co-filers
Chief Financial Officer
Option exercise3,055
holds 0 after
$0.00—
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, Chief Financial Officer
Option exercise1,536
holds 3,072 after
$0.00—
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, President, CDG
Option exercise1,152
holds 2,304 after
$0.00—
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, President, LSG
Option exercise1,056
holds 2,112 after
$0.00—
DMC
DEL MONTE CORP
4 co-filers
SVP, NA Sales, Mkt & Prd Mgmt
Option exercise884
holds 884 after
$0.00—
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, Global Supply Chain
Option exercise864
holds 1,728 after
$0.00—
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
EVP, General Counsel & Sec
Option exercise768
holds 1,536 after
$0.00—
BIO
BIO-RAD LABORATORIES, INC.
3 co-filers
Group filing
Option exercise92
holds 185 after
$0.00—
DMC
DEL MONTE CORP
4 co-filers
SVP, NA Sales, Mkt & Prd Mgmt
Option exercise64$0.00—
← 2026-09-052026-09-07 →

Source: SEC Form 4 filings. Descriptive only — not investment advice.